Public Information for Fiscal Year 2025 Payments
- *Companies that have disclosed information regarding payments for fiscal year 2025 have been removed from the “Disclosed Information for Fiscal Year 2024” section.
Horizontal scrolling is available
| Release date (A.D.) | Company name | Disclosure screen URL |
|---|---|---|
| September 11, 2026 | CHUGAI PHARMACEUTICAL CO., LTD. |
https://www.chugai-pharm.co.jp/sustainability/ethics/transparency/index.html |
| September 10, 2026 | Merck Biopharma Co., Ltd. | |
| September 9, 2026 | AstraZeneca K.K. | |
| September 1, 2026 | Eisai Co., Ltd. |
https://www.eisai.co.jp/sustainability/society/disclosure/disclosure2/index.html |
| August 31, 2026 | OTSUKA PHARMACEUTICAL Co., Ltd. |
https://www.otsuka.co.jp/company/corporate-governance/patient/ |
| August 31, 2026 | EA Pharma Co., Ltd. | |
| August 31, 2026 | DAIICHI SANKYO CO., LTD. |
https://www.daiichisankyo.co.jp/about_us/info_disclosure/toumeisei_patients/ |
| August 20, 2026 | SENJU PHARMACEUTICAL CO., LTD. |